Effects of long-term memantine on memory and neuropathology in Ts65Dn mice, a model for Down syndrome
- 10 August 2011
- journal article
- Published by Elsevier BV in Behavioural Brain Research
- Vol. 221 (2), 610-622
- https://doi.org/10.1016/j.bbr.2010.03.036
Abstract
No abstract availableThis publication has 84 references indexed in Scilit:
- Cholinergic degeneration and memory loss delayed by vitamin E in a Down syndrome mouse modelExperimental Neurology, 2009
- Memantine leads to behavioral improvement and amyloid reduction in Alzheimer's‐disease‐model transgenic mice shown as by micromagnetic resonance imagingJournal of Neuroscience Research, 2008
- Effects of Memantine on Neuronal Structure and Conditioned Fear in the Tg2576 Mouse Model of Alzheimer's DiseaseNeuropsychopharmacology, 2008
- Episodic-like memory in Ts65Dn, a mouse model of Down syndromeBehavioural Brain Research, 2008
- Memantine for the Treatment of Alzheimer???s DiseaseDrug Safety, 2008
- Long-Term Consequences of Methamphetamine Exposure in Young Adults Are Exacerbated in Glial Cell Line-Derived Neurotrophic Factor Heterozygous MiceJournal of Neuroscience, 2007
- Effect of Subchronic Treatment of Memantine, Galantamine, and Nicotine in the Brain of Tg2576 (APPswe) Transgenic MiceThe Journal of pharmacology and experimental therapeutics, 2005
- The Neuroprotective Agent Memantine Induces Brain-Derived Neurotrophic Factor and trkB Receptor Expression in Rat BrainMolecular and Cellular Neuroscience, 2001
- Deficient glutamate tranport is associated with neurodegeneration in Alzheimer's diseaseAnnals of Neurology, 1996
- A behavioral assessment of Ts65Dn mice: a putative Down syndrome modelNeuroscience Letters, 1995